Comtan (entacapone), a new COMT inhibitor for advanced Parkinson's disease

Novartis is now marketing Comtan (entacapone), a new COMT inhibitor for advanced Parkinson's disease. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote